|
S&P Pharmaceutical Company Limited - Company Profile Snapshot
| Company Profile: |
S&P Pharmaceutical Company Limited |
| Ticker: |
600869 |
| Exchanges: |
SHG |
| 2008 Sales: |
204,160,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
CHINA |
| Employees: |
816 |
Business Description
S&P Pharmaceutical Company Limited Formerly known as S&P Pharmaceutical Industry Company Limited. The Group's principal activities are the research, development, manufacture and sale of Chinese, OTC drugs and Tibetan medicines and health products. Other activities include the wholesale and retail of Chinese and biological products. These products are for cardiovascular and respiratory systems in the form of solutions and capsules. Products include Chongcaojing (an essence made from Chinese caterpillar fungus), Chongcao Shensi oral liquid, Yiganjian (hepatitis medicine) and Xinnaoxin (Tibetan medicine for diseases caused by shortage of oxygen), among others. Operations of the Group are carried out in the People's Republic of China.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
